FY2025 · ended Dec 31, 2025 · Revenue $133.93M, +14.2% YoY · Filed Mar 31, 2026
Xtant Medical Holdings, Inc. (XTNT) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $133.9 million and net income of $5.0 million. Free cash flow was $10.2 million. As of Jun 30, 2026 it held $9.9 million in cash and investments and $14.0 million in total debt.
Revenue (TTM)
$109.53M
-14.3% vs year-ago TTM
Net income (TTM)
$-11.14M
-143.2% vs year-ago TTM
Operating cash flow (TTM)
$570,000
-62.0% vs year-ago TTM
Free cash flow (TTM)
$-696,000
+75.4% vs year-ago TTM
EPS (TTM)
$-0.08
-137.5% vs year-ago TTM
Dividend per share
None
Shares outstanding
140.07M
+0.7% vs prior year
Net cash
$-4.17M
as of Jun 30, 2026
Operating margin
-9.6%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- XTNT (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Belgrade, MT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1453593
- Former names
- Bacterin International Holdings, Inc. (until Aug 3, 2015); K KITZ INC (until May 21, 2010)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $133.9M | $117.3M | $91.3M | $58.0M | $55.3M |
| Operating income | $7.3M | -$12.1M | -$10.2M | -$6.8M | -$3.9M |
| Net income | $5.0M | -$16.4M | $660,000 | -$8.5M | -$4.8M |
| Diluted EPS | $0.03 | -$0.12 | $0.01 | -$0.09 | -$0.06 |
| Operating cash flow | $12.5M | -$11.9M | -$9.5M | -$5.3M | $439,000 |
| Free cash flow | $10.2M | -$16.0M | -$11.0M | -$7.1M | -$1.7M |
| Total assets | $94.1M | $93.8M | $92.6M | $60.2M | $54.7M |
| Total liabilities | $43.2M | $50.9M | $41.3M | $26.1M | $23.8M |
| Stockholders' equity | $51.0M | $43.0M | $51.3M | $34.2M | $30.9M |
| Cash and investments | $17.1M | $6.2M | $5.7M | $20.3M | $18.2M |
| Total debt | $17.9M | $23.0M | $18.9M | $13.7M | $13.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Aug 7, 2026 | Aug 7, 2026 |
| ARS | Annual report to shareholders | Jun 23, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
May 13, 2026 | May 13, 2026 |
All 1000 Xtant Medical Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.